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Define the term artificial
oocyte and its potential
applications.
Provide an overview of the main
pluripotent stem cells used to derive
oocytes, emphasising in why iPSCs
are a promising source.
Review the limitations of this
technology and the barriers that
need to be overcome before
applying this approach in clinic.
CONCLUSIONS REFERENCES
Oogenesis is a dynamic process
involving the ovarian niche and a
continuous interaction between oocyte
and somatic cells.
 
It is important to mimic this niche as much as
possible.
Before applying these findings to
clinic, further research will be
needed to ensure the safety of
the process in terms of oocyte
viability and functionality. 
Ensure a healthy offspring.
iPSCs are a powerful and promising
source for future oocyte obtention,
with clinical and scientific
applications. 
However, the efficiencies of obtaining
mature cells are low, so this field is still in
experimentation and more research is
needed.
iPSCs
Niu et al., 2013
Panula et al., 2011
Medrano et al., 2012
Yamashiro et al., 2018
Reference
Anchan et al., 2015
Hayashi et al., 2012
Hikabe et al., 2016
Adherent culture: EBs formation + PFF + RA OLCs
Expression of ZP3.
Ovarian-like structures that seemed to contain follicle-like structures.
EpiLCs and PGCLCs induction, through
rOvaries and in vivo transplantation
Adherent culture: overexpression of germ
line genes + induction with BMPs
Spontaneous differentiation + culture with
germ line inductors
Starting of the epigenetic reprogramming, elimination of parental
imprinting and reactivation of X chromosome.
Differentiation  method




Dependent on an in vivo system.
Complete in vitro process.
iMeLCs and PGCLCs induction
iMeLCs and PGCLCs induction, through
xrOvaries
Expression of PGCs markers.
Expression of PGCs markers, but increased methylation of  H19.
Gene expression similar to day 7 PGCs.
iPSCs  source Derived cells Offspring Remarks
miPSCs
Expression of ZP1 and early gametogenesis and ovarian markers.








Eguizabal et al., 2011
Sasaki et al., 2015
Suspension culture
Embryoid bodies (EBs) formation
Co-aggregation with somatic ovarian cells





Gene transduction: overexpression of key genes




In vivo transplantation of
iPSCs to the ovaries
Clinical application: generation of gametes from
infertile patients, allowing them to have genetically
related offspring.
Scientific application: creation of an in vitro system




The main objective is to COLLECT THE MAIN STRATEGIES TO DERIVE OOCYTES FROM iPSCs IN VITRO, as well as the most
important results to date. Moreover, there are secondary objectives:
Stem cells are non-(fully) specialised cells that can differentiate into different cell types under certain
conditions.
Although embryonic stem cells (ESCs) have been classically proposed as a therapeutic alternative, induced
pluripotent stem cells (iPSCs) have further potential applications.
Auto-immune cells can be generated from patient's own somatic cells, thus avoiding ethical concerns and
the possible post-transplantation immune rejection.
Artificial oocytes are mature eggs generated in vitro by specification and maturation of
primordial germ cells (PGCs) or by direct differentiation of pluripotent cells to the
female germ-cell lineage. 
They should be able to undergo fertilisation and embryogenesis, in
order to transmit their genetic and epigenetic information to the next
generation.
An extensive search was made mainly in  PubMed
and Google Scholar databases, using the
appropriated combination of keywords and
Boolean operators. Results were filtered by date
in order to obtain the latest results, and by impact
factor of the journal. 
FUTURE APPLICATIONS OF ARTIFICIAL OOCYTESSTRATEGIES TO DERIVE GERM CELLS FROM PLURIPOTENT STEM CELLS
STATE OF THE ART
Table 1. Relevant results of the state of the art about the obtention of oocytes from mouse and human iPSCs (miPSCs / hiPSCs).
Abbreviations. Embryoid bodies (EBs), porcine follicular fluid (PFF), retinoic acid (RA), Epiblast-like cells (EpiLCs), primordial germ cell-like cells (PGCLCs), reconstituted ovaries (rOvaries), bone morphogenetic proteins (BMPs), incipient mesoderm-like cells (iMeLCs), xenogeneic reconstituted ovaries (xrOvaries), oocyte-like cells (OLCs), zona pellucida (ZP), primordial
germ cells (PGCs).
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Can oocytes be generated from
iPSCs?
?
EpiLCs and PGCLCs induction, through
rOvaries and in vivo transplantation
Metaphase II oocytes Dependent on an in vivo system. miPSCs from granulosa cells. Tian et al., 2019
